3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1368.5

Change

+0.50 (+0.04)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-27 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

N/A

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

N/A

USD 0.31B
0648:HK CHINA RENJ

N/A

USD 0.12B
0177-OL:HK JIANGSU EXPRESS

+0.06 (+0.60%)

N/A
0240-OL:HK BUILD KING HOLD

-0.02 (-1.92%)

N/A
0243-OL:HK QPL INT'L

N/A

N/A
0182-OL:HK CHINA WINDPOWER

N/A

N/A
0259-OL:HK YEEBO (INT'L H)

-0.05 (-3.01%)

N/A
0187-OL:HK JINGCHENG MAC

-0.05 (-1.11%)

N/A

ETFs Containing 3020-OL:HK

DXZ:CA Dynamic Active U.S. Mid-C.. 11.35 % 0.87 %

+0.12 (+0.45%)

CAD 0.04B
IHF iShares U.S. Healthcare P.. 10.79 % 0.43 %

+0.44 (+0.45%)

N/A
TETF 6.19 % 0.64 %

N/A

N/A
FHI:CA CI Health Care Giants Cov.. 5.55 % 0.75 %

+0.11 (+0.45%)

CAD 0.10B
FHI-B:CA CI Health Care Giants Cov.. 5.55 % 0.00 %

N/A

CAD 0.05B
IAI iShares U.S. Broker-Deale.. 4.11 % 0.42 %

+3.10 (+0.45%)

N/A
LONG:CA CI Global Longevity Econo.. 4.01 % 0.00 %

+0.53 (+0.45%)

CAD 3.64M
CBUF:XETRA iShares MSCI World Health.. 3.16 % 0.00 %

+0.05 (+0.45%)

N/A
PSL Invesco DWA Consumer Stap.. 3.12 % 0.60 %

+1.02 (+0.45%)

USD 0.09B
HDIV 2.83 % 0.00 %

N/A

N/A
TDOC:CA TD Global Healthcare Lead.. 2.34 % 0.00 %

+0.08 (+0.45%)

CAD 0.08B
FHH-F:CA First Trust AlphaDEX U.S... 2.32 % 0.00 %

N/A

CAD 0.01B
FLXG:LSE 1.87 % 0.00 %

N/A

N/A
FRGE:LSE 1.87 % 0.00 %

N/A

N/A
RYH 1.72 % 0.40 %

N/A

N/A
DSTL Distillate US Fundamental.. 1.58 % 0.00 %

+0.92 (+0.45%)

USD 1.89B
HONR 1.20 % 0.65 %

N/A

N/A
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.08 (+0.45%)

USD 0.10B
JKH iShares Morningstar Mid-C.. 0.00 % 0.30 %

N/A

N/A
KCE SPDR® S&P Capital Market.. 0.00 % 0.35 %

+2.97 (+0.45%)

N/A
RYF 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.64 (+0.45%)

N/A
WBIF WBI BullBear Value 3000 E.. 0.00 % 1.05 %

+0.55 (+0.45%)

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+13.63 (+0.45%)

N/A
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.19 (+0.45%)

N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.17 (+0.45%)

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.06 (+0.45%)

N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.04 (+0.45%)

N/A
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

+1.30 (+0.45%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.70% 52% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.70% 52% F 51% F
Trailing 12 Months  
Capital Gain 12.59% 69% C- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.59% 66% D+ 66% D+
Trailing 5 Years  
Capital Gain 107.51% 83% B 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 107.51% 83% B 85% B
Average Annual (5 Year Horizon)  
Capital Gain 14.78% 77% C+ 75% C
Dividend Return 14.78% 74% C 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.91% 79% B- 81% B-
Risk Adjusted Return 82.49% 95% A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike